About this trial
The main objective of this study is to estimate the prevalence of childbirth-related post-traumatic stress disorder (PTSD) among mothers treated at the maternity ward of Emile Muller Hospital (Mulhouse, Haut-Rhin, France).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Women aged 18 or older
Having given birth in the maternity ward at Emile Muller Hospital (Mulhouse, Haut-Rhin, France)
Fluent in French
Having provided written consent to participate in the study
Disqualifiers
Women who gave birth anonymously
Women who gave birth to a stillborn child or a fetus that died in utero
Women under legal protection (guardianship, conservatorship, judicial protection).
Trial design
Single group
Treatments tested in this trial
City Birth Trauma Scale and Questionnaire on the assessment of healthcare utilization
Diagnostic testAbout one month after giving birth, patients who have given their consent will receive an email containing a personal link to the eCRF page with the French version of the City Birth Trauma Scale (CBTS) questionnaire, as well as a questionnaire to assess their use of healthcare services. After completing the CBTS questionnaire, the participant can choose to check a box in the eCRF to indicate whether or not she wishes to be contacted by the research team in the event that her score suggests a diagnosis of PTSD.
Treatment groups
Trial outcomes
Primary outcomes
City Birth Trauma Scale
The diagnosis of PTSD based on responses to the questionnaire will be made in accordance with the questionnaire's scoring method, which assesses 8 criteria based on the DSM-5 (criteria labeled A through H).
Secondary outcomes
Questionnaire on the assessment of healthcare utilization
A ten-item questionnaire to assess the use of healthcare services in the context of postpartum post-traumatic stress disorder from the women's perspective, enquiring about the healthcare professionals these women consulted during the month following childbirth.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: